Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hybrid heart fix combines bypass and stents – but study stalls

NCT ID NCT03788369

First seen Jan 10, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study looked at a hybrid approach for treating multiple blocked heart arteries: a minimally invasive bypass for the main artery plus stents for others. Only 6 people took part before the study was stopped early. The goal was to see if this combination is safe and effective in real-world practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY STENOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hybrid coronary revascularization (minimally invasive bypass surgery plus stenting)

What this could lead to

If successful, this approach could offer a less invasive alternative to open-heart surgery for people with multiple blocked arteries.

What could go wrong

The study was terminated early and enrolled only 6 people, so results are very limited. The procedure still carries risks like heart attack, stroke, or need for repeat treatment.

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.